Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin.

Woo Cheal ChoRayan SaadePriyardhisini Nagarajan Leomar Y BallesterDenái R MiltonMario L Marques-PiubelliCourtney HudgensDebora LedesmaKelly NelsonDoina IvanMiao ZhangCarlos A Torres-CabalaMatthew CampbellOmar Alhalabi Victor G PrietoIgnacio I WistubaBita EsmaeliJonathan L Curry

Published in: Journal of cutaneous pathology (2024)

Increased Nectin-4 expression in a subset of cutaneous adnexal carcinomas, particularly sebaceous carcinomas, reveals that EV is a potential therapeutic option for these tumors.

Keyphrases

poor prognosis
high grade
binding protein
hodgkin lymphoma
stem cells
mesenchymal stem cells
cell therapy
replacement therapy